[Chronic low-grade inflammation, lipid risk factors and mortality in functionally dependent elderly]

Olga Vasović1, Danijela Trifunović, Nebojsa Despotovié

  • 1Gradski zavod za gerontologiju, Beograd, Srbija. vasovic.odndm@ptt.rs

Vojnosanitetski Pregled
|August 17, 2010
PubMed

Insights

High hsCRP levels indicate chronic inflammation and predict mortality in functionally dependent elderly. Aggressive lipid-lowering treatment may benefit those with high hsCRP and elevated total cholesterol.

Area of Science:

  • Cardiovascular Risk Assessment
  • Inflammation Biomarkers
  • Geriatric Medicine

Context:

  • Aging is associated with decreased HDL-C and LDL-C, and increased cardiovascular risk.
  • Chronic low-grade inflammation, indicated by hsCRP, is a known predictor of mortality.
  • Functionally dependent elderly represent a vulnerable population with complex health needs.

Purpose:

  • To investigate the association between chronic low-grade inflammation (hsCRP) and lipid risk factors.
  • To determine the importance of hsCRP in predicting all-cause mortality in functionally dependent elderly.
  • To explore the potential impact of hsCRP levels on treatment strategies for cardiovascular risk.

Summary:

  • This longitudinal study analyzed 257 functionally dependent elderly individuals (65-99 years).
  • hsCRP levels were correlated with obesity indicators and triglyceride levels, and inversely with HDL-C.
  • High hsCRP combined with elevated total cholesterol significantly predicted all-cause mortality (OR=3.71).

Impact:

  • Identifies high hsCRP as a crucial marker for identifying high-risk elderly individuals.
  • Suggests that aggressive lipid-lowering therapy may be particularly beneficial for elderly patients with high hsCRP.
  • Highlights the interplay between inflammation, lipid profiles, and mortality in a vulnerable geriatric population.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Inflammation01:38

Inflammation

Overview
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...